# Safety and Pharmacokinetics Study of Multiple Ascending Doses of VV261 Tablets

> **NCT07710326** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Vigonvita Life Sciences** · enrollment: 16 (estimated)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** VV261 600mg TID group
- **DRUG:** VV261 900mg TID group

## Key facts

- **NCT ID:** NCT07710326
- **Lead sponsor:** Vigonvita Life Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08-01
- **Primary completion:** 2026-11-30
- **Final completion:** 2026-11-30
- **Target enrollment:** 16 (ESTIMATED)
- **Last updated:** 2026-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07710326

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07710326, "Safety and Pharmacokinetics Study of Multiple Ascending Doses of VV261 Tablets". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07710326. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*